Effects of huoxianzhengqi liquid on enteric mucosal immune responses in mice with Bacillus dysenteriae and Salmonella typhimurium induced diarrhea

World Journal of Gastroenterology

Volumn 12, Issue 45, 2006, Pages 7346-7349

  He, Yin Hui ^a   Zhao, Hong Yan ^b   Liu, Zhen Li ^b   Lu, Cheng ^b   Luo, Xiao Jian ^a   Lin, Se Qi ^a   Qian, Xing Wen ^a   Chen, Shi Lin ^c   Lu, Ai Ping ^b,d  

^a JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation)   (China)

^d SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Diarrhea; Huoxiang zhengqi liquid; Peyer's patches; TNF

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHINESE DRUG; HUOXIANGZHENGQI; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT; HERBACEOUS AGENT; HUOXIANG ZHENGQI; HUOXIANG-ZHENGQI;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIARRHEA; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOREGULATION; INTESTINE MUCOSA; LOW DRUG DOSE; MALE; MOUSE; MOUSE STRAIN; MUCOSAL IMMUNITY; NONHUMAN; PERIPHERAL LYMPHOCYTE; PEYER PATCH; PROTEIN BLOOD LEVEL; SALMONELLA TYPHIMURIUM; SHIGELLA DYSENTERIAE; STUDENT T TEST; TISSUE HOMOGENATE; ANIMAL; BACILLUS; BACTERIAL INFECTION; BAGG ALBINO MOUSE; DRUG EFFECT; MICROBIOLOGY; SALMONELLOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACILLUS; BACTERIAL INFECTIONS; DIARRHEA; DRUGS, CHINESE HERBAL; FEMALE; MALE; MICE; MICE, INBRED BALB C; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 33845512526     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i45.7346     Document Type: Article

References (24)

1. Xie YC, Tang F. Experimental study on protecting intestinal barrier function of Huoxiang Zhengqi soft capsule. Zhongguo Zhongyao Zazhi 2004; 29: 456-458
2. Wu Z, Kuang L, Zhang G, Pan Z, Li F, Hu X. Quality control for huoxiang-zhengqi liquid. Zhongguo Zhongyao Zazhi 1998; 23: 223-225, 255
3. Zhang WD, Zhou QS, Yang ZL. Clinical and experimental study on wenchangning oral liquor in treating infantile autumn diarrhea. Zhongguo Zhongxiyi Jiehe Zazhi 1996; 16: 454-458
4. Dubinsky MC, Taylor K, Targan SR, Rotter JI. Immunogenetic phenotypes in inflammatory bowel disease. World J Gastroenterol 2006; 12: 3645-3650
5. Endsley JJ, Quade MJ, Terhaar B, Roth JA. Bovine viral diarrhea virus type 1- and type 2-specific bovine T lymphocyte-subset responses following modified-live virus vaccination. Vet Ther 2002; 3: 364-372
6. Anton PM, O'Brien M, Kokkotou E, Eisenstein B, Michaelis A, Rothstein D, Paraschos S, Kelly CP, Pothoulakis C, Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters. Antimicrob Agents Chemother 2004; 48: 3975-3979
7. Itoh K, Oowada T, Mitsuoka T. Characteristic faecal flora of NC mice. Lab Anim 1985; 19: 7-15
8. Wiedermann U. Mucosal immunity-mucosal tolerance. A strategy for treatment of allergic diseases. Chem Immunol Allergy 2003; 82: 11-24
9. Michalek SM, Katz J, Childers NK, Martin M, Balkovetz DF. Microbial/host interactions: mechanisms involved in host responses to microbial antigens. Immunol Res 2002; 26: 223-234
10. Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998; 62: 1157-1170
11. Granucci F, Ricciardi-Castagnoli P. Interactions of bacterial pathogens with dendritic cells during invasion of mucosal surfaces. Curr Opin Microbiol 2003; 6: 72-76
12. Kelly D, Conway S. Bacterial modulation of mucosal innate immunity. Mol Immunol 2005; 42: 895-901
13. Rhee KJ, Sethupathi P, Driks A, Lanning DK, Knight KL. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J Immunol 2004; 172: 1118-1124
14. Heel KA, McCauley RD, Papadimitriou JM, Hall JC. Review: Peyer's patches. J Gastroenterol Hepatol 1997; 12: 122-136
15. Cunningham-Rundles S. The effect of aging on mucosal host defense. J Nutr Health Aging 2004; 8: 20-25
16. Miniello VL, Moro GE, Armenio L. Prebiotics in infant milk formulas: new perspectives. Acta Paediatr Suppl 2003; 91: 68-76
17. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, Fitzgibbon J, O'Sullivan GC, Kiely B, Collins JK, Shanahan F. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003; 52: 975-980
18. Losacco T, De Leo G, Punzo C, Pellegrino NM, Neri V, D'Eredita G, Di Ciaula G, Pitzalis MV. Immune evaluations in cancer patients after colorectal resection. G Chir 1994; 15: 429-432
19. Zhang ZX, Young K, Zhang L. CD3+CD4-CD8- alphabeta-TCR+ T cell as immune regulatory cell. J Mol Med 2001; 79: 419-427
20. Kanauchi O, Fukuda M, Matsumoto Y, Ishii S, Ozawa T, Shimizu M, Mitsuyama K, Andoh A. Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J Gastroenterol 2006; 12: 1071-1077
21. Lin F, Spencer D, Hatala DA, Levine AD, Medof ME. Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease. J Immunol 2004; 172: 3836-3841
22. Van Assche G, Rutgeerts P. Anti-TNF agents in Crohn's disease. Expert Opin Investig Drugs 2000; 9: 103-111
23. Kollias G, Kontoyiannis D. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev 2002; 13: 315-321
24. Kirman I, Whelan RL, Nielsen OH. Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004; 16: 639-641